F.D.A. Rejects Closely Watched Lung Cancer Drug From China

New York Times - Nov 15, 2026

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

Read full article

More News

About Us
Logo

In-Depth Science delivers comprehensive and compelling news and analysis on everything science and technology, seven days a week in a reader-friendly format.

Contact us: sales[at]indepthscience.com

Copyright © 2015 - 2026 In-Depth Science. All Rights Reserved.